Anders Koch terapi ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 10.1% 15.2% 13.6%  
Credit score (0-100)  0 0 23 12 15  
Credit rating  N/A N/A BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 608 620 979  
EBITDA  0.0 0.0 -15.0 -188 -66.4  
EBIT  0.0 0.0 -15.0 -188 -66.4  
Pre-tax profit (PTP)  0.0 0.0 -26.0 -215.0 -80.4  
Net earnings  0.0 0.0 -22.0 -170.0 -129.7  
Pre-tax profit without non-rec. items  0.0 0.0 -26.0 -215 -80.4  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 18.0 -152 -282  
Interest-bearing liabilities  0.0 0.0 5.0 256 174  
Balance sheet total (assets)  0.0 0.0 167 429 86.0  

Net Debt  0.0 0.0 -106 -19.0 158  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 608 620 979  
Gross profit growth  0.0% 0.0% 0.0% 2.0% 57.9%  
Employees  0 0 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 167 429 86  
Balance sheet change%  0.0% 0.0% 0.0% 156.9% -80.0%  
Added value  0.0 0.0 -15.0 -188.0 -66.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% -2.5% -30.3% -6.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -9.0% -50.3% -14.0%  
ROI %  0.0% 0.0% -65.2% -134.8% -30.9%  
ROE %  0.0% 0.0% -122.2% -76.1% -50.4%  

Solidity 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  0.0% 0.0% 10.8% -26.2% -76.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 706.7% 10.1% -238.3%  
Gearing %  0.0% 0.0% 27.8% -168.4% -61.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 440.0% 20.7% 6.5%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.0 0.0 0.8 0.6 0.1  
Current Ratio  0.0 0.0 0.8 0.6 0.1  
Cash and cash equivalent  0.0 0.0 111.0 275.0 16.0  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -31.0 -218.0 -347.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -15 -188 -66  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -15 -188 -66  
EBIT / employee  0 0 -15 -188 -66  
Net earnings / employee  0 0 -22 -170 -130